US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 9.830
  • +0.630+6.85%
Close Jun 28 16:00 ET
  • 10.000
  • +0.170+1.73%
Post 19:40 ET
1.57BMarket Cap-6166P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neumora Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.34

-45.02%
Analyst Rating

Buy

May 31, 2024

Neumora Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Neumora Therapeutics Earnings Reports

  • Neumora Therapeutics | 10-Q: Quarterly report

    May 7 16:08 ET

  • Neumora Therapeutics | 10-K: Annual report

    Mar 7 16:14 ET

  • Neumora Therapeutics | 10-Q: Quarterly report

    Nov 1, 2023 16:05 ET

    • Analysis

    Analyst Rating

    Updated: May 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg